FDA-filed SPL labeling · retrieved through openFDA

Mometasone

Mometasone is a corticosteroid available in nasal, inhaled, topical, and sinus implant forms, used to treat seasonal allergic rhinitis, chronic rhinosinusitis with nasal polyps, asthma, and inflammatory skin conditions.

Brand names PropelAsmanexNasonexSinuvaMometasone Furoate +11 more
Drug class Corticosteroid Hormone Receptor Agonists
Rx/OTC Forms 5 Routes Topical · Nasal · Respiratory (inhalation) · Intrasinal
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 37 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveJun 7, 2023
Clinical labels in scope 37
AvailabilityRx/OTC
Earliest approval/marketing year 1987
FDA-listed product records 187
Boxed warningNone found in compared labels
How we combine label and product data →
No current FDA shortage listed · checked Sep 22, 2026 🚨Recall on record · 2
Other forms & routes:
Mometasone at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Mometasone is a versatile corticosteroid available as a nasal spray, inhaler, skin cream or ointment, and sinus implant — each form approved for specific conditions like seasonal allergies, asthma, nasal polyps, or inflammatory skin conditions. It controls inflammation effectively but is not a quick-relief option, and it works best when used consistently as directed. Talk to your pharmacist or doctor about the right form for your condition and any precautions that apply to you.

📖 Mometasone: Patient Information Guide

A plain-language walkthrough of Mometasone — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for

Mometasone is a corticosteroid available in multiple forms, each approved for specific uses — so the form and brand matter.

  • Nasal spray (mometasone furoate monohydrate / mometasone furoate nasal spray, Nasonex): Prevents nasal symptoms of seasonal allergic rhinitis in adults and children 12 and older; treats chronic rhinosinusitis with nasal polyps in adults 18 and older
  • OTC nasal spray (Nasonex OTC and store brands): Temporarily relieves hay fever and upper respiratory allergy symptoms including congestion, runny nose, sneezing, and itchy nose
  • Asmanex Twisthaler (inhaled dry powder): Long-term maintenance treatment of asthma in patients 4 years and older; not for acute bronchospasm
  • Asmanex HFA (inhaled aerosol): Long-term maintenance treatment of asthma in patients 5 years and older; not for acute bronchospasm
  • Topical cream and ointment (0.1%): Relieves inflammation and itching from corticosteroid-responsive skin conditions in patients 2 years and older
  • Topical lotion/solution (0.1%): Relieves inflammation and itching from corticosteroid-responsive skin conditions in patients 12 years and older
  • Sinuva sinus implant: Treats chronic rhinosinusitis with nasal polyps in adults 18 and older who have already had ethmoid sinus surgery; placed by an ENT physician
⚙️How it works

Mometasone is a potent corticosteroid that binds to glucocorticoid receptors inside cells — the same receptors your body's own stress hormone (cortisol) uses. This triggers a broad anti-inflammatory effect: it quiets immune cells like mast cells and eosinophils and reduces the release of inflammatory chemicals like histamine and leukotrienes that cause swelling, itching, and airway narrowing. When applied to the right tissue — nasal passages, lungs, or skin — this calming effect directly targets the source of symptoms.

Because it works by changing how cells behave rather than by blocking a single chemical instantly, mometasone takes time to reach its full effect. With inhaled use for asthma, maximum benefit may not arrive for one to two weeks or longer after starting treatment.

💊How it's taken

The right dose and timing depend entirely on which form of mometasone you are using — so always follow your prescriber's directions for your specific product.

  • Nasal spray: Typically 2 sprays in each nostril once daily for allergic rhinitis (adults and children 12+); twice daily for nasal polyps in adults. The OTC children's version (ages 2–11) uses 1 spray per nostril once daily. Prime the pump before first use and reprime if unused for more than a week.
  • Asmanex Twisthaler / Asmanex HFA (inhaled): Inhaled twice daily by mouth. After each use, rinse your mouth with water and spit it out — do not swallow. This reduces the risk of a yeast infection in the mouth. Maximum benefit may take 1–2 weeks or longer.
  • Topical cream or ointment: A thin film applied to affected skin once daily. Stop when the skin clears; if no improvement in 2 weeks, contact your doctor. Do not use on the face, groin, or underarms unless directed, and avoid airtight coverings over the treated area.
  • Sinuva sinus implant: Inserted by an ENT doctor in an office setting; gradually releases medication for up to 90 days, then is removed.
🤒Side effects — in detail

The most common side effects vary by how mometasone is used, but across all forms the ones reported most often include:

  • Headache
  • Sore throat (pharyngitis) and upper respiratory infections
  • Oral yeast infection (thrush) — most common with inhaled forms; rinsing your mouth after each dose greatly reduces this risk
  • Sinusitis
  • Nasal irritation or nosebleeds (nasal spray)
  • Muscle or back pain (inhaled forms)
  • Stomach upset or indigestion (inhaled forms)
  • Skin irritation, burning, or thinning (topical forms)

More serious reactions to watch for include sudden severe breathing problems, signs of a serious allergic reaction (throat swelling, hives, anaphylaxis), eye pain or vision changes with long-term use, and in children, slower-than-expected growth — all of these warrant a call to your doctor promptly.

⚠️Warnings & precautions
  • Not for emergency use: Inhaled mometasone (Asmanex) does not work fast enough to treat a sudden asthma attack. Always have a rescue inhaler (like albuterol) available. If an attack is not responding to rescue treatment, seek emergency care.
  • Mouth and throat yeast infection: Inhaled corticosteroids can cause Candida (thrush) — white patches in the mouth or throat. Rinsing and spitting after every dose helps prevent this.
  • Immune suppression: Corticosteroids can make infections like chickenpox or measles more dangerous. If you haven't had these illnesses or been vaccinated, take steps to avoid exposure. Use with extra caution if you have tuberculosis, a fungal infection, herpes of the eye, or other active infections.
  • Adrenal suppression: If you are switching from oral steroids to inhaled or nasal mometasone, do not stop oral steroids suddenly. Your adrenal glands need months to recover, and during stress, surgery, or illness you may need extra corticosteroid support.
  • Bone density: Long-term inhaled corticosteroid use can reduce bone mineral density. People with risk factors for osteoporosis should be monitored.
  • Eye effects: Long-term use has been linked to glaucoma (increased eye pressure) and cataracts. Report any eye symptoms to your doctor.
  • Children's growth: Nasal and inhaled corticosteroids may slow growth in children. A doctor should monitor height regularly and use the lowest effective dose.
  • Paradoxical bronchospasm: Rarely, the inhaler can trigger immediate worsening of wheezing. Stop use immediately and use a rescue bronchodilator if this happens.
🔀What it interacts with

Mometasone has a relatively limited interaction profile, but one category matters significantly:

  • Strong CYP3A4 inhibitors — including ketoconazole, ritonavir, cobicistat (and cobicistat-containing HIV medications), atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, and telithromycin — can block the enzyme that breaks down mometasone. This raises mometasone levels in the blood and increases the risk of systemic steroid side effects like adrenal suppression. Use together with caution and watch for steroid-related side effects.
  • Short-acting bronchodilators and intranasal corticosteroids used alongside inhaled mometasone have not shown increased adverse effects in clinical trials, but always tell your prescriber about all medications you take.

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it
  • Allergic to milk proteins? Asmanex Twisthaler is contraindicated — it contains milk proteins. Tell your doctor before using it.
  • Active infections: Tell your doctor if you have tuberculosis, an untreated fungal, bacterial, viral, or parasitic infection, or herpes of the eye — mometasone can make these harder to fight.
  • Switching from oral steroids: A slow, supervised taper is essential. Stopping oral steroids too quickly when starting mometasone can leave your adrenal glands unable to respond to stress.
  • Pregnancy: Animal studies showed fetal effects at certain doses, though nasal use results in minimal systemic absorption. Discuss the benefits and risks with your doctor.
  • Breastfeeding: Nasal use leads to very little systemic absorption; the infant is not expected to be exposed through breast milk. Still, discuss with your doctor.
  • Children: Different minimum ages apply by product. Monitor growth regularly with nasal or inhaled forms. Topical cream and ointment: approved age 2+; lotion: approved age 12+. Nasal polyp use is not established under age 18.
  • Liver disease: Mometasone levels may be higher in people with hepatic impairment; your doctor should be aware of this.
  • Older adults: Clinical studies showed no notable difference in safety or effectiveness compared to younger adults, but standard steroid precautions still apply.
🚑If you take too much

There are no reports of acute overdose problems with mometasone nasal spray, and because very little is absorbed into the bloodstream through the nose, serious effects from an accidental extra dose are unlikely. That said, using more than directed over a long period can lead to signs of too much cortisol in the body — called hypercorticism — such as weight gain around the face and midsection, easy bruising, or fatigue. If you think you or someone else has used too much, contact your doctor or a poison control center.

📡Pharmacodynamics — effects in the body

When used as a nasal spray at recommended doses, mometasone showed no statistically significant effect on the body's cortisol levels in multiple studies — meaning it works locally in the nasal passages without meaningfully suppressing the adrenal glands at normal doses. With inhaled use (Asmanex), some measurable reduction in 24-hour cortisol levels has been observed at higher doses, consistent with the known systemic effects of inhaled corticosteroids. This is why staying at the lowest effective dose matters, especially for long-term use.

🔬Pharmacokinetics — how your body processes it

Mometasone is designed to act locally with minimal absorption into the bloodstream. With nasal use, systemic bioavailability is very low. With oral inhalation (Asmanex HFA), the drug is absorbed with peak blood levels reached within about 30 minutes to 2 hours. Oral bioavailability is negligible — meaning that any swallowed drug is not meaningfully absorbed. The main pathway for breaking down mometasone in the body is through a liver enzyme called CYP3A4, which is why drugs that block that enzyme can raise mometasone blood levels significantly.

📦How to store it

Store at 20° to 25°C (68° to 77°F) . Avoid excessive heat.

📄 Written from Mometasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Mometasone — the kind of thing our pharmacy team would talk through with you at the counter.

Can I use my mometasone nasal spray or inhaler when I'm having an allergy attack or asthma flare right now?
For the nasal spray, it can help with allergy symptoms, but it works best as a daily preventive — not a quick-fix spray you grab when symptoms hit suddenly. For the inhalers (Asmanex Twisthaler or HFA), the answer is no — they are not rescue medications. They control asthma over time by reducing airway inflammation, but they won't open your airways quickly during an attack. If you're having an asthma flare, use your short-acting rescue inhaler (like albuterol) and contact your doctor if it's not helping.
I've been using the Asmanex inhaler for a week and I still feel the same. Is it working?
That's actually normal — it can take one to two weeks or even longer to feel the full benefit from an inhaled corticosteroid like Asmanex. These medications work by gradually reducing airway inflammation, not by providing instant relief. Keep using it as prescribed, don't skip doses, and give it a bit more time. If you're still not improving after a couple of weeks, let your prescriber know.
My doctor just prescribed mometasone cream for my skin. Are there any spots I should avoid putting it on?
Yes — avoid applying it to your face, groin, or underarms unless your doctor specifically tells you to. You should also keep it away from your eyes. Don't cover the treated area with a tight or airtight wrap (like plastic wrap or a diaper on a child in that area) unless directed, because that can increase how much steroid is absorbed through the skin. Apply a thin layer once a day and stop when the skin clears up. If things don't improve within two weeks, check back in with your doctor.
I've heard that mouth infections can happen with inhalers. How do I avoid that?
You're right — a yeast infection called oral thrush (white patches in the mouth or throat) can happen with inhaled corticosteroids. The good news is there's a simple step that greatly reduces your risk: after every single dose, rinse your mouth with water, swish it around, and spit it out — don't swallow. That washes away residual medication sitting on the mouth and throat tissue. If you ever notice white patches or soreness in your mouth, let your doctor know — it's very treatable.
Is it safe to use this if I'm pregnant or breastfeeding?
For the nasal spray, very little mometasone gets into the bloodstream, so exposure to a baby through the bloodstream or breast milk is expected to be minimal. That said, animal studies did show some fetal effects at certain doses, so it's worth discussing the benefits and risks with your doctor rather than just assuming it's fine. If you're breastfeeding, the nasal spray is not expected to result in meaningful exposure to your infant, but again — keep your doctor in the loop so they can weigh in based on your full situation.
I was on oral prednisone for a long time and my doctor is switching me to an inhaled mometasone. Do I just stop the prednisone?
Definitely not — this is one of the most important things to get right. After being on oral steroids for a while, your adrenal glands (which normally make your body's own cortisol) need time to wake back up and work on their own again. Stopping oral steroids too quickly can leave you without enough cortisol to handle stress, illness, or surgery — which can be dangerous. Your doctor should set up a slow, gradual taper off the oral steroids while you start the inhaler. During that transition, watch for warning signs like extreme fatigue, weakness, nausea, or dizziness, and contact your doctor right away if those appear.
Is Mometasone available over the counter?
Both — Mometasone is sold both over the counter and by prescription, according to its FDA labeling. Lower strengths or certain forms are often available without a prescription, while higher strengths or specialized forms still require one. Ask your pharmacist which version is right for you.
When was Mometasone first available?
Mometasone has been available in the United States since at least 1987, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Mometasone?
Mometasone is supplied by 64 manufacturers listed in the FDA NDC Directory, including Bryant Ranch Prepack, Organon LLC, Preferred Pharmaceuticals Inc..

💬 Answers drafted from Mometasone’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Mometasone comes

Mometasone is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Topical cream, ointment or gel

On the skin
Brands Mometasone Furoate
Available strengths 3 strengths
75 FDA-listed product records

Nasal spray

In the nose
Brands Allergy Allergy Nasal Allergy Relief Basic Care Allergy Childrens Nasonex Leader Allergy Nasal Leader Nasal Mometasone Furoate Mometasone Furoate Monohydrate Nasonex Rugby mometasone furoate nasal Topcare Allergy
Available strengths 1 strength
34 FDA-listed product records

Topical solution

On the skin
Brands Mometasone Furoate
Available strengths 1 strength
13 FDA-listed product records

Insert or device

By mouth · Intrasinal
Brands Sinuva
Available strengths 1 strength
3 FDA-listed product records

📊 Mometasone across the U.S. market

How Mometasone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

5
Dose forms
64
Manufacturers
16
Brand names
187
FDA-listed product records
1987
First marketed

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (38) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack16%
Organon LLC11%
Preferred Pharmaceuticals Inc.5%
Padagis Israel Pharmaceuticals Ltd4%
L. Perrigo Company4%
Glenmark Pharmaceuticals Inc., USA4%
Other makers56%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Mometasone is used

A general measure of how commonly Mometasone is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Mometasone is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

666,398
Medicaid prescriptions filled (Q1–Q4 2025)
$25M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Mometasone prescribed? Of the 1,596 medications we measure, Mometasone ranks #225 by Medicaid prescriptions — more than 86% of them.

Where Mometasone ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Mometasone product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 1 mg/mL topical cream is the most-dispensed Mometasone product — about 32% of these Medicaid prescriptions.

mometasone furoate 1 MG/ML Topical Cream Most dispensed

212,025 Medicaid prescriptions (Q1–Q4 2025) 32% of Mometasone prescriptions shown $4.1M gross reimbursement (before rebates) ≈ $19 per prescription (gross)

Summed across the 4 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311753

mometasone furoate 0.001 MG/MG Topical Ointment

204,546 Medicaid prescriptions (Q1–Q4 2025) 31% of Mometasone prescriptions shown $3.7M gross reimbursement (before rebates) ≈ $18 per prescription (gross)

Summed across the 4 of 29 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 151029

mometasone furoate 1 MG/ML Topical Lotion

77,800 Medicaid prescriptions (Q1–Q4 2025) 12% of Mometasone prescriptions shown $2M gross reimbursement (before rebates) ≈ $25 per prescription (gross)

Summed across the 4 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 151030

mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray

51,854 Medicaid prescriptions (Q1–Q4 2025) 8% of Mometasone prescriptions shown $2.1M gross reimbursement (before rebates) ≈ $41 per prescription (gross)

Summed across the 8 of 32 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1797865

Other Mometasone products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)

120,173 Medicaid prescriptions (Q1–Q4 2025) 18% of Mometasone prescriptions shown $13.1M gross reimbursement (before rebates) ≈ $109 per prescription (gross)

Summed across the 8 of 96 listed NDC products with Medicaid activity.

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Mometasone, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 28 of 200 listed Mometasone NDCs with Medicaid activity.

🔍 Compare Mometasone products

A representative set of FDA-listed product records for Mometasone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 187 of 187 products — FDA National Drug Code Directory. See every product, package size and price: browse all 187 Mometasone NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Mometasone RxCUI 108118 7 dose forms · 14 strengths
  1. Dose form (SCDF) Drug Implant RxCUI 1148518 In current FDA listings
    Clinical drug / strength (SCD) furoate 0.37 MG RxCUI 1148519 furoate 1.35 MG RxCUI 1995983
  2. Dose form (SCDF) Dry Powder Inhaler RxCUI 746792 No current FDA listing
    Clinical drug / strength (SCD) 14 ACTUAT mometasone furoate 0.22 MG/ACTUAT RxCUI 746810 30 ACTUAT mometasone furoate 0.11 MG/ACTUAT RxCUI 790283 30 ACTUAT mometasone furoate 0.22 MG/ACTUAT RxCUI 746812 60 ACTUAT mometasone furoate 0.22 MG/ACTUAT RxCUI 746814 120 ACTUAT mometasone furoate 0.22 MG/ACTUAT RxCUI 746803
  3. Dose form (SCDF) Metered Dose Inhaler RxCUI 1536141 In current FDA listings
    Clinical drug / strength (SCD) 120 ACTUAT mometasone furoate 0.05 MG/ACTUAT RxCUI 2196790 120 ACTUAT mometasone furoate 0.1 MG/ACTUAT RxCUI 1536142 120 ACTUAT mometasone furoate 0.2 MG/ACTUAT RxCUI 1536147
  4. Dose form (SCDF) Metered Dose Nasal Spray RxCUI 1797864 In current FDA listings
    Clinical drug / strength (SCD) furoate 0.05 MG/ACTUAT RxCUI 1797865
  5. Dose form (SCDF) Topical Cream RxCUI 619083 In current FDA listings
    Clinical drug / strength (SCD) furoate 1 MG/ML RxCUI 311753
  6. Dose form (SCDF) Topical Lotion RxCUI 619119 In current FDA listings
    Clinical drug / strength (SCD) furoate 1 MG/ML RxCUI 151030
  7. Dose form (SCDF) Topical Ointment RxCUI 619042 In current FDA listings
    Clinical drug / strength (SCD) furoate 0.001 MG/MG RxCUI 151029

Look up RxCUI 108118 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Propel Asmanex Nasonex Sinuva Mometasone Furoate Asmanex Hfa allergy topcare allergy allergy nasal Childrens Nasonex Rugby mometasone furoate nasal Allergy Relief basic care allergy Leader Allergy Nasal Leader Nasal Mometasone Furoate Monohydrate

🏭 Manufacturers & labelers

Bryant Ranch Prepack 26 Organon LLC 18 Preferred Pharmaceuticals Inc. 8 Padagis Israel Pharmaceuticals Ltd 7 L. Perrigo Company 6 Glenmark Pharmaceuticals Inc., USA 6 Cosette Pharmaceuticals, Inc. 6 A-S Medication Solutions 5 Proficient Rx LP 4 RPK Pharmaceuticals, Inc. 4 Industriale Chimica s.r.l. 4 Torrent Pharmaceuticals Limited 3 Topco Associates LLC 3 Kindeva Drug Delivery Limited 3 NuCare Pharmaceuticals,Inc. 3 Golden State Medical Supply, Inc. 3 Apotex Corp. 3 Sun Pharmaceutical Industries, Inc. 3 Amneal Pharmaceuticals LLC 3 E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 3 Taro Pharmaceuticals U.S.A., Inc. 3 Coral Drugs Private Limited 3 Aarti Pharmalabs Limited 2 Amazon.com Services LLC 2

…and 16 more on the FDA NDC directory.

RxNorm drug class

Mometasone belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids, potent (group III), Corticosteroids, Glucocorticoids
How it works Corticosteroid Hormone Receptor Agonists

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jun 7, 2023
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Mometasone.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Mometasone after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
37
NDC products indexed
187
Distinct labelers/manufacturers represented
64
Linked representative label
RPK Pharmaceuticals, Inc.
Linked label effective
Jun 7, 2023
Composite sections available
23
Linked SPL Set ID
015a259c-a0cb-4440-b8f2-0a31aa76fb88
Linked SPL Document ID
401dc847-735d-4d83-ab20-28a28abd429e
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 37 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. RPK Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.